Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate)
Arielle Elkrief, Siddhartha P. Duttagupta, R. Jamal, Nicolas Marcoux, Antoine Desîlets, Meriem Messaoudene, Catalin Mihalcioiu, Sylvère Durand, M. Tehfe, N. Blais, Sioned Owen, J. Raphael, John Lenehan, Seema Nair Parvathy, L. Derosa, L. Zitvogel, Guido Guido Kroemer, Michael H. Silverman, Saman Maleki Vareki, Bertrand Routy (2024). 1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate). , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.1126.
Article233 days agoLBA62 Phase I trial of camu camu prebiotic plus immunotherapy in patients with melanoma and non-small cell lung cancer (NSCLC)
Jade Maillou, Meriem Messaoudene, Reilly Pidgeon, Diogjena Katerina Prifti, I. Ben Aissa, J. Malo, Guido Guido Kroemer, Marine Fidelle, Lisa Derosa, Olivier Barbier, Nathalie Daaboul, N. Blais, M. Tehfe, M. Florescu, R. Jamal, Antoine Desîlets, Wilson H. Miller, Bastien Castagner, Arielle Elkrief, B. Routy (2025). LBA62 Phase I trial of camu camu prebiotic plus immunotherapy in patients with melanoma and non-small cell lung cancer (NSCLC). , 36, DOI: https://doi.org/10.1016/j.annonc.2025.09.074.
Article32 days ago